No profile data available.
AVAI BIO, INC. (AVAI) is a technology company in the application development services industry, based in Vilnius, Lithuania.
It reported revenue of $0 for fiscal year 2026, and net income of -$1.75 million. In Q1 2027 (the quarter ended June 30, 2026) revenue was $0. Its market capitalization was $17.55 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2026; market data as of October 9, 2026.
Avaí Bio, Inc. acquires, creates, and develops artificial intelligence (AI) technologies. It also offers information technology (IT) consulting services. The company provides full-stack software development, database management, data integration, project management and cloud services resources. It also offers Avant!
AVAI BIO reported $0 in revenue for fiscal year 2026. In Q1 2027 revenue was $0.
$17.55 million as of October 9, 2026.
Listed companies of a similar size in the same industry (application development services) include CTW Cayman (CTW), Endava plc (DAVA), Alpha Technology Group Limited (ATGL), Aluf Holdings, Inc. (AHIX).